The ACRO Podcast is developed by the nation's leading radiation oncologists and is designed to provide clinicians and program leaders with critically important clinical, business, and advocacy content to advance cancer care and the careers of those professionals we represent. The ACRO Podcast is the latest tool developed by the American College of Radiation Oncology which is the essential professional society for success in the day-to-day practice of radiation oncology.
In the first episode of Reimbursement Matters, ACRO’s Dr. Jared Pasetsky and Teri Bedard from RCCS discuss three timely reimbursement and coverage issues affecting radiation oncology. The conversation covers the 2027 proposed Medicare rules, evolving coverage for radiation therapy used to treat benign disease and recent claims challenges affecting radiation oncology practices. They break down what’s changing, what practices should be watching and practical steps to consider in the months ahead. Reimbursement Matters is a quarterly podcast from ACRO and RCCS focused on the reimbursement and coverage issues shaping radiation oncology. Interested in learning more about the ACROinsights article discussed in this episode? Check it out here (https://cdn.ymaws.com/acro.org/resource/resmgr/files/advocacy/insights/2026-2-acroinsights-coverage.pdf) and learn more at acro.org/advocacy (https://acro.org/page/advocacy).
30 Jul 2026
CURiE Conversations: Small-Cell Carcinoma of the Bladder With Concurrent High-Grade Prostate Cancer: A Case Report and Review of the Literature
In this episode of CURiE Conversations, host Dr. Jessica Schuster speaks with Dr. Veronia Fahmy and Dr. James S. Welsh about their published work, "Small-Cell Carcinoma of the Bladder With Concurrent High-Grade Prostate Cancer: A Case Report and Review of the Literature."The discussion explores the management of this rare synchronous malignancy, the rationale for bladder-preserving chemoradiotherapy, the role of hypofractionated radiation and the clinical decision to use MRI surveillance instead of prophylactic cranial irradiation. They also reflect on how reviewing the limited literature surrounding rare cancers helped guide treatment.Contemporary Updates: Radiotherapy Innovation & Evidence (CURiE) is the official publication platform of the American College of Radiation Oncology through the Cureus Journal of Medical Science. Read the full article here: https://www.cureus.com/articles/502342-small-cell-carcinoma-of-the-bladder-with-concurrent-high-grade-prostate-cancer-a-case-report-and-review-of-the-literature
8 Jun 2026
CURiE Conversations: Definitive Radiotherapy in Serous Carcinoma of Unknown Primary With Isolated Nodal Disease: A Case Review
In this episode of CURiE Conversations, host Dr. Veronia Fahmy speaks with Nneoma Uzoukwu and Dr. Jeremy Price about their published work, "Definitive Radiotherapy in Serous Carcinoma of Unknown Primary: A Case Review."
The discussion explores the presentation and management of serous carcinoma of unknown primary with isolated nodal disease, the rationale for definitive radiotherapy and key considerations for multidisciplinary cancer care.
Contemporary Updates: Radiotherapy Innovation & Evidence (CURiE) is the official publication platform of the American College of Radiation Oncology through the Cureus Journal of Medical Science. Read the full article here: https://www.cureus.com/articles/479202-definitive-radiotherapy-in-serous-carcinoma-of-unknown-primary-with-isolated-nodal-disease-a-case-review
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
3.7 / 5
3 ratings
Podcast Authority Score: 42 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
57
Social presence
0
YouTube
0
Engagement
67
Contact ACRO Podcast
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
